Financhill
Back

Bicara Therapeutics Stock Predictions

Bicara Therapeutics Stock Forecast

  • Is Bicara Therapeutics Stock Undervalued?
    The current Bicara Therapeutics [BCAX] share price is $18.09. The Score for BCAX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • BCAX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Bicara Therapeutics Stock Go Up Next Year?

Data Unavailable

Bicara Therapeutics Stock Rating

Data Unavailable

Bicara Therapeutics Stock Price History

Is BCAX stock going to rise?

  • The current trend is relatively stagnant and BCAX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:

52-Week Data

52-Week High:
28.09
52-Week Low:
17.41

Prediction Charts

Market Cap:
832.61M
Price in USD:
18.09
Volume:
415.06K
Beta:
0.00

Technical Analysis

SMA50:
0.00
SMA100:
0.00
SMA200:
0.00
52-Wk Change:
0%

Stock Predictions

  • Is Bicara Therapeutics stock public?
    Yes, Bicara Therapeutics is a publicly traded company.
  • What is the Bicara Therapeutics stock quote today?
    The Bicara Therapeutics stock price is 18.09 USD today.
  • How to buy Bicara Therapeutics stock online?
    You can buy Bicara Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 25.09 25.19 26.00 24.31
Nov-6 25.81 23.68 28.09 23.67
Nov-7 23.77 23.60 25.09 23.27
Nov-8 23.59 23.82 24.70 23.16
Nov-11 24.10 24.11 24.59 23.36
Nov-12 23.91 22.33 24.15 22.10
Nov-13 22.35 22.00 23.17 21.82
Nov-14 21.80 22.25 23.15 21.59
Nov-15 22.22 20.17 24.09 19.95
Nov-18 19.74 19.20 21.19 18.73
Nov-19 19.13 19.32 19.78 18.77
Nov-20 19.23 18.38 20.79 17.62
Nov-21 18.41 17.77 18.83 17.41
Nov-22 17.51 18.09 18.72 17.51

Bicara Therapeutics Earnings

Data Unavailable

Bicara Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.26 per share.

* Bicara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.